CYTK · Cytokinetics Inc
United States · RS rating 36 · As of 2026-11-03
| Price | 62.31 USD |
|---|---|
| 1-day change | +0.5% |
| RS rating (overall / 1M / 3M / 12M) | 36 / 55 / 30 / 49 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 42 / 22 / 40 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +41.2% |
| Sales growth Q/Q | +817.1% |
| Distance from 52-week high | +28.6% |
| Market cap (USD) | $8.1B |